Amicogen, Inc.

KOSDAQ:A092040 Stock Report

Market Cap: ₩206.7b

Amicogen Balance Sheet Health

Financial Health criteria checks 1/6

Amicogen has a total shareholder equity of ₩214.2B and total debt of ₩180.0B, which brings its debt-to-equity ratio to 84%. Its total assets and total liabilities are ₩489.8B and ₩275.5B respectively.

Key information

84.0%

Debt to equity ratio

₩180.03b

Debt

Interest coverage ration/a
Cash₩25.69b
Equity₩214.25b
Total liabilities₩275.52b
Total assets₩489.77b

Recent financial health updates

Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Jun 19
Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Is Amicogen (KOSDAQ:092040) A Risky Investment?

Feb 15
Is Amicogen (KOSDAQ:092040) A Risky Investment?

Recent updates

Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Nov 11
Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Jun 27
Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Jun 19
Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

Mar 21
Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

With EPS Growth And More, Amicogen (KOSDAQ:092040) Is Interesting

Mar 23
With EPS Growth And More, Amicogen (KOSDAQ:092040) Is Interesting

Should Amicogen (KOSDAQ:092040) Be Disappointed With Their 24% Profit?

Mar 05
Should Amicogen (KOSDAQ:092040) Be Disappointed With Their 24% Profit?

Is Amicogen (KOSDAQ:092040) A Risky Investment?

Feb 15
Is Amicogen (KOSDAQ:092040) A Risky Investment?

What Kind Of Investors Own Most Of Amicogen, Inc. (KOSDAQ:092040)?

Jan 31
What Kind Of Investors Own Most Of Amicogen, Inc. (KOSDAQ:092040)?

Could The Market Be Wrong About Amicogen, Inc. (KOSDAQ:092040) Given Its Attractive Financial Prospects?

Jan 14
Could The Market Be Wrong About Amicogen, Inc. (KOSDAQ:092040) Given Its Attractive Financial Prospects?

Amicogen (KOSDAQ:092040) Is Growing Earnings But Are They A Good Guide?

Dec 30
Amicogen (KOSDAQ:092040) Is Growing Earnings But Are They A Good Guide?

Is Now The Time To Put Amicogen (KOSDAQ:092040) On Your Watchlist?

Dec 15
Is Now The Time To Put Amicogen (KOSDAQ:092040) On Your Watchlist?

Did You Miss Amicogen's (KOSDAQ:092040) 37% Share Price Gain?

Nov 30
Did You Miss Amicogen's (KOSDAQ:092040) 37% Share Price Gain?

Financial Position Analysis

Short Term Liabilities: A092040's short term assets (₩152.4B) do not cover its short term liabilities (₩176.9B).

Long Term Liabilities: A092040's short term assets (₩152.4B) exceed its long term liabilities (₩98.6B).

Debt to Equity History and Analysis

Debt Level: A092040's net debt to equity ratio (72%) is considered high.

Reducing Debt: A092040's debt to equity ratio has increased from 22% to 84% over the past 5 years.

Debt Coverage: A092040's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if A092040's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y